J. B. Chemicals & Pharmaceuticals Limited J. B. Chemicals & Pharmaceuticals Limited

J. B. Chemicals & Pharmaceuticals Limited

JBCHEPHARM

株式のランク #3892
J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai,... J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai, India, in 1976, specializes in the development, production, and global distribution of diverse pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. Among its prominent product offerings are Cilnidipine, Ranitidine, and Metronidazole. Beyond its own brands, the company extends comprehensive contract manufacturing services, covering an extensive spectrum of dosage forms such as tablets, various lozenge types, injectables, gels, creams, ointments, liquid herbal syrups, and capsules. The firm further contributes to diagnostic medicine by supplying contrast agents for advanced imaging techniques like X-ray, MRI, and ultrasound. Its therapeutic expertise encompasses a broad range of medical fields, including gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance.
株価
$26.58
最終同期: 2026-07-23
時価総額
$4.24B
変化(1日)
0.00%
変化(1年)
38.14%
国
IN
取引 J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)

カテゴリー

Healthcare
J. B. Chemicals & Pharmaceuticals Limited(JBCHEPHARM)の利益
Mar 2026 時点の利益 TTM: $105.10M
J. B. Chemicals & Pharmaceuticals Limited の最新の財務報告によると、同社の現在の利益は $105.10M です。2024 年には $90.13M の利益を上げ、これは 2023 年の利益 $67.56M と 増加 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
J. B. Chemicals & Pharmaceuticals Limited の利益の推移(2005 〜 2026)
各年末の利益
年 利益 変化
2026 (TTM) $105.10M 1.29%
2025 $103.76M 15.12%
2024 $90.13M 33.40%
2023 $67.56M 1.58%
2022 $66.51M -18.43%
2021 $81.54M 76.06%
2020 $46.31M 12.06%
2019 $41.33M 38.74%
2018 $29.79M -15.99%
2017 $35.46M 12.49%
2016 $31.52M 35.13%
2015 $23.33M 59.89%
2014 $14.59M -23.47%
2013 $19.06M -88.54%
2012 $166.34M 348.33%
2011 $37.10M 12.53%
2010 $32.97M 351.68%
2009 $7.30M -33.14%
2008 $10.92M -33.49%
2007 $16.41M -11.60%
2006 $18.57M 22.45%
2005 $15.16M 0.00%